LXRX: Lexicon Pharmaceuticals Inc

LXRX News

• 03:59 Lexicon Pharmaceuticals’ Strategic Retrenchment Will Take Years To Show Results (LXRX)
• 16:00 Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know
• 16:53 Jefferies raises Lexicon Pharmaceuticals stock price target to $0.85
• 12:53 Lexicon Q2 2025 slides: Strategic pivot yields profit as pipeline advances
• 12:45 Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates
• 11:46 Lexicon earnings beat by $0.10, revenue topped estimates
• 22:35 Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue Estimates
• 12:06 Lexicon Pharmaceuticals regains Nasdaq compliance
• 11:44 Lexicon Pharmaceuticals regains Nasdaq compliance for minimum bid price
• 11:21 Lexicon Q1 2025 slides: EPS beat, revenue miss, strategic partnerships advance
• 11:39 H.C. Wainwright reiterates buy rating on Lexicon Pharmaceuticals stock
• 12:44 Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
• 12:58 Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
• 12:58 Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
• 11:04 Lexicon Pharmaceuticals surges 67% following InvestingPro’s Fair Value signal
• 18:21 Lexicon Pharmaceuticals at Jefferies Conference: Strategic Partnerships and Pipeline Progress
• 12:32 Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
• 15:07 Lexicon at H.C. Wainwright Conference: Strategic Pipeline Developments
• 12:16 SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
• 15:00 Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
• 13:00 Top 2 Health Care Stocks That May Crash This Month - Lexicon Pharmaceuticals (NASDAQ:LXRX), Amarin Corp (NASDAQ:AMRN)
• 09:29 US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst - Babcock & Wilcox (NYSE:BW), AAR (NYSE:AIR)
• 22:10 Lexicon's Drug Discovery Engine Validated By Novo's Obesity Drug Deal
• 13:41 Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Lexicon Pharmaceuticals (NASDAQ:LXRX), DBV Technologies (NASDAQ:DBVT)